The 4th edition of this highly successful conference will focus on the latest advances in 3D-based cellular models and emerging topics in the areas of cell architecture, mechanobiology, the immune microenvironment, high level imaging and high-content analysis for cancer therapeutics. The conference format is designed to encourage networking in order to develop approaches that translate to outcomes.
Who should attend? Faculty, postdocs, and trainees interested in the techniques and applications of 3D culture at the intersection of cancer biology, engineering, and drug development.
Industry scientists interested in identifying promising platforms for drug discovery and targets for novel therapies.